Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Five Prime Therapeutics Inc (NASDAQ:FPRX)

52.49
Delayed Data
As of 3:59pm ET
 +0.65 / +1.25%
Today’s Change
14.70
Today|||52-Week Range
55.00
+26.48%
Year-to-Date
No recent news for Five Prime Therapeutics Inc.

Today’s Trading

Previous close51.84
Today’s open52.11
Day’s range51.47 - 53.07
Volume326,776
Average volume (3 months)478,910
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-125.68%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,874.94%
P/E ratio5.7
Price/Sales2.95
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
HALOHalozyme Therapeutic...+0.18+1.51%
XLRNAcceleron Pharma Inc-0.22-0.60%
ONCESpark Therapeutics I...+1.66+2.84%
CHRSCoherus BioSciences ...+0.49+1.86%
Data as of 4:00pm ET, 09/30/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$379.8M
Annual profit (last year)$249.6M
Net profit margin65.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Lewis T. Williams
Chief Operating Officer &
Director
Aron M. Knickerbocker
Corporate headquarters
South San Francisco, California

Forecasts

Search for Jobs